Trade War Expansion? STAR Board Aims To Keep Lucrative China Biotech IPOs At Home

 
• By Brian Yang
  
Money Wave
CHIPSCREEN AMONG FIRST BIOPHARMAS TO GO PUBLIC ON SHANGHAI'S NEW STAR BOARD • Source: Shutterstock

More from China

More from Focus On Asia